Found 1 articles for: "IL-1 Inhibition"

Experience of a Single Academic Center Using IL-1 Inhibition for Rare Dermatologic Conditions

February 2022 | Volume 21 | Issue 2 | Editorials | 206 | Copyright © February 2022

Evidence-based literature regarding management of rare and severe dermatologic disease is limited. Canakinumab and anakinra, two therapeutics used for inhibiting IL-1 pathways, have seen increased uti...
Read More